// App-Quantinova.ai

POS09 : Novel sirolimus-eluting stent with a biodegradable polymer in the all-comers population - 1-year results with angiographic and OCT analysis

Researchers

Presenter

  • Bil J

Principal Investigators

  • Gil R

  • Kern A

  • Pawlowski T

  • Seweryniak P

  • Sliwinski Z

Medical Centers

  • Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland

  • Faculty of Medical Sciences University of Varmia and Masuria, Olsztyn, Poland

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Stable coronary artery disease

  • Myocardial infarction

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Tumor protein p63

Drug/Treatment

  • sirolimus

  • ZoMaxx

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved